USP2-45 represses aldosterone mediated responses by decreasing mineralocorticoid receptor availability

Cellular Physiology and Biochemistry

Volumn 31, Issue 2-3, 2013, Pages 462-472

  Faresse, Nourdine ^a,b   Debonneville, Anne ^b   Staub, Olivier ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Aldosterone; Nuclear receptor; Post translational modification; Proteasome; Ubiquitin

Indexed keywords

ALDOSTERONE; LUCIFERASE; MINERALOCORTICOID RECEPTOR; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE 2 45; UNCLASSIFIED DRUG; DEUBIQUITINASE; MINERALOCORTICOID; UBIQUITIN SPECIFIC PROTEASE USP2 45;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HORMONE RESPONSE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY CELL; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; UBIQUITINATION; GENETIC TRANSFECTION; PROTEIN STABILITY; WILD TYPE;

EID: 84876003253     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000343382     Document Type: Article

References (34)

1. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM: Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor. Science 1987;237:268-275. (Pubitemid 17095145)
2. Staub O, Loffing J: Mineralocorticoid action in the aldosterone sensitive distal nephron; in Alpern RJ, Caplan MJ, Moe OW (eds): The kidney: Physiology and pathophysiology. London, Waltham, San Diego, Adademic Press, 2013, vol 1, pp 1181-1211.
3. Geller DS, Rodriguezsoriano J, Boado AV, Schifter S, Bayer M, Chang SS, Lifton RP: Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type i. Nat Genet 1998;19:279-281. (Pubitemid 28309343)
4. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP: Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 2000;289:119-123. (Pubitemid 30463305)
5. Shibata S, Fujita T: Mineralocorticoid receptors in the pathophysiology of chronic kidney diseases and the metabolic syndrome. Mol Cell Endocrinol 2012;350:273-280.
6. Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH: Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: The 4e-left ventricular hypertrophy study. Circulation 2003;108:1831-1838. (Pubitemid 37296092)
7. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M: Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321. (Pubitemid 36384098)
8. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators. N Engl J Med 1999;341:709-717. (Pubitemid 29407370)
9. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombes M: The mineralocorticoid receptor: Insights into its molecular and (patho)physiological biology. Nucl Recept Signal 2007;5:e012.
10. Faresse N, Vitagliano JJ, Staub O: Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation. FASEB J 2012;26:4373-4382.
11. Weissman AM, Shabek N, Ciechanover A: The predator becomes the prey: Regulating the ubiquitin system by ubiquitylation and degradation. Nat Rev Mol Cell Biol 2011;12:605-620.
12. Komander D, Clague MJ, Urbe S: Breaking the chains: Structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009;10:550-563.
13. Nijman SM, Luna-Vargas MP, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, Bernards R: A genomic and functional inventory of deubiquitinating enzymes. Cell 2005;123:773-786. (Pubitemid 41721026)
14. Lin H, Keriel A, Morales CR, Bedard N, Zhao Q, Hingamp P, Lefrancois S, Combaret L, Wing SS: Divergent n-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures. Mol Cell Biol 2000;20:6568-6578. (Pubitemid 30650241)
15. Gousseva N, Baker RT: Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms usp2-45 and usp2-69. Gene Expr 2003;11:163-179. (Pubitemid 37516649)
16. Fakitsas P, Adam G, Daidie D, van Bemmelen MX, Fouladkou F, Patrignani A, Wagner U, Warth R, Camargo SM, Staub O, Verrey F: Early aldosterone-induced gene product regulates the epithelial sodium channel by deubiquitylation. J Am Soc Nephrol 2007;18:1084-1092. (Pubitemid 46536894)
17. Ruffieux-Daidie D, Poirot O, Boulkroun S, Verrey F, Kellenberger S, Staub O: Deubiquitylation regulates activation and proteolytic cleavage of enac. J Am Soc Nephrol 2008;19:2170-2180.
18. Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP: Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology 2006;147:1343-1348. (Pubitemid 43244368)
19. Faresse N, Ruffieux-Daidie D, Salamin M, Gomez-Sanchez CE, Staub O: Mineralocorticoid receptor degradation is promoted by hsp90 inhibition and the ubiquitin-protein ligase chip. Am J Physiol Renal Physiol 2010;299:F1462-1472.
20. Rogerson FM, Dimopoulos N, Sluka P, Chu S, Curtis AJ, Fuller PJ: Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. J Biol Chem 1999;274:36305-36311.
21. Tallec LP, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A, Lombes M: Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the n-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: Implication of small ubiquitin-related modifier 1 modification. Mol Endocrinol 2003;17:2529-2542. (Pubitemid 37542215)
22. Haglund K, Dikic I: Ubiquitylation and cell signaling. EMBO J 2005;24:3353-3359. (Pubitemid 41486773)
23. Staub O, Rotin D: Role of ubiquitylation in cellular membrane transport. Physiol Rev 2006;86:669-707.
24. Faus H, Haendler B: Post-translational modifications of steroid receptors. Biomed Pharmacother 2006;60:520-528.
25. Ma Y, Fan S, Hu C, Meng Q, Fuqua SA, Pestell RG, Tomita YA, Rosen EM: Brca1 regulates acetylation and ubiquitination of estrogen receptor-alpha. Mol Endocrinol 2010;24:76-90.
26. Burgdorf S, Leister P, Scheidtmann KH: Tsg101 interacts with apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated transcription by promoting its monoubiquitination. J Biol Chem 2004;279:17524-17534. (Pubitemid 38560516)
27. Ismaili N, Blind R, Garabedian MJ: Stabilization of the unliganded glucocorticoid receptor by tsg101. J Biol Chem 2005;280:11120-11126. (Pubitemid 40418417)
28. Bedard N, Yang Y, Gregory M, Cyr DG, Suzuki J, Yu X, Chian RC, Hermo L, O'Flaherty C, Smith CE, Clarke HJ, Wing SS: Mice lacking the usp2 deubiquitinating enzyme have severe male subfertility associated with defects in fertilization and sperm motility. Biol Reprod 2011;85:594-604.
29. Le Menuet D, Viengchareun S, Penfornis P, Walker F, Zennaro MC, Lombes M: Targeted oncogenesis reveals a distinct tissue-specific utilization of alternative promoters of the human mineralocorticoid receptor gene in transgenic mice. J Biol Chem 2000;275:7878-7886. (Pubitemid 30159695)
30. Mazo EB, Koriakin MV, Kudriavtsev Iu V, Evseev LP, Akopian AS: [The role of disorders of mineralocorticoid function of the adrenal glands in the development of infertility in patients with left-side varicocele]. Urol Nefrol (Mosk) 1989;2:38-45.
31. Scoma HD, Humby M, Yadav G, Zhang Q, Fogerty J, Besharse JC: The de-ubiquitinylating enzyme, usp2, is associated with the circadian clockwork and regulates its sensitivity to light. PLoS One 2011;6:e25382.
32. Mirshahi M, Nicolas C, Mirshahi A, Hecquet C, d'Hermies F, Faure JP, Agarwal MK: The mineralocorticoid hormone receptor and action in the eye. Biochem Biophys Res Commun 1996;219:150-156. (Pubitemid 26071619)
33. Golestaneh N, Picaud S, Mirshahi M: The mineralocorticoid receptor in rodent retina: Ontogeny and molecular identity. Mol Vis 2002;8:221-225. (Pubitemid 36153611)
34. Zhao M, Valamanesh F, Celerier I, Savoldelli M, Jonet L, Jeanny JC, Jaisser F, Farman N, Behar-Cohen F: The neuroretina is a novel mineralocorticoid target: Aldosterone up-regulates ion and water channels in muller glial cells. FASEB J 2010;24:3405-3415.